Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development - Wikidata - wikimedia - TriplyDB

Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development

Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development

http://www.wikidata.org/entity/Q34915928

about

The Valley of Death in anticancer drug development: a reassessment Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell Targeting The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and Xenografts.Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.Cancer nanomedicines targeting tumor extracellular pH.In vivo tumour extracellular pH monitoring using electron paramagnetic resonance: the effect of X-ray irradiation.DNA topoisomerase-targeting chemotherapeutics: what's new?Targeting ion transport in cancer

P2860

Q26861274-7B34CFA2-0799-43C7-A5D3-60209707DF28 Q28534332-83A0CCFC-0AFB-4040-990C-4BB853F1181B Q30417706-D98BB5FD-952F-4A8E-BC72-88E060FD960D Q36031889-B1F47037-0640-49FE-84B7-EBC37FCB008F Q37955451-A639C950-F4E3-441B-8022-B160EECDDCF6 Q38370504-2E5E51E0-C5DB-4745-99B6-FEF24A226EAD Q39320242-E9C44534-94B6-4270-AEE0-9E6471007B80 Q41930187-435AD431-D5A2-40EB-BC13-48420EDF0A59

P2860

Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development

http://www.wikidata.org/entity/Q34915928

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tumor physiology and charge dy ...... othecin-based drug development

@ast

Tumor physiology and charge dy ...... othecin-based drug development

@en

Tumor physiology and charge dy ...... othecin-based drug development

@nl

type

label

Tumor physiology and charge dy ...... othecin-based drug development

@ast

Tumor physiology and charge dy ...... othecin-based drug development

@en

Tumor physiology and charge dy ...... othecin-based drug development

@nl

prefLabel

Tumor physiology and charge dy ...... othecin-based drug development

@ast

Tumor physiology and charge dy ...... othecin-based drug development

@en

Tumor physiology and charge dy ...... othecin-based drug development

@nl

P1433

Q34915928-E1898F53-BA5A-4B62-9999-686782693723

P1476

Q34915928-D54B1854-EFC7-47E2-AE8F-1E5A4ABB8C89

P2093

Q34915928-6F6413DE-F659-4638-84EF-9F5B8E150481

Q34915928-89ADE04A-A736-4447-814C-0A0710B72A3A

P2860

Q34915928-014AFD7E-7319-42B6-B5A1-D5ECF0BB0737

Q34915928-0B8ED241-A4CD-4D29-A7A3-ACBC42B37C32

Q34915928-0CF2D03E-B03E-4AA6-B217-6FEFFA7183B9

Q34915928-13628301-064C-44B1-BC1F-1F4BF617526C

Q34915928-17C384DA-1534-4B8F-91F6-CC017E055310

Q34915928-1E183E04-A8F4-498B-B6C5-09C8071880DB

Q34915928-2176C0D3-C442-40AB-B23B-77A89D0EF334

Q34915928-29F12581-69E7-4DA1-8B10-8965544BEE4C

Q34915928-2A90BA92-2D5C-47C4-8D35-98B952449E55

Q34915928-3C24EB39-31CC-4B84-A13C-84D0D81FC651

P304

Q34915928-53840AC4-A58D-4711-83E2-3ED8F447506F

P31

Q34915928-923728F5-6A4E-4E3F-9C45-ECF75F0A5199

P356

Q34915928-CF9999D9-AB8A-4E1C-8634-06149C6863E8

P433

Q34915928-DD6A8556-7EEA-4A04-8224-CC10376278C1

P478

Q34915928-8E3823C3-484B-41E3-BDC1-A875DDED2BC5

P577

Q34915928-F1874E7D-FE5D-4B87-A7C4-83790759344A

P5875

Q34915928-F013F01A-CC0C-4230-A4AF-D588A9A65B2A

P698

Q34915928-B3E0CFA5-5F2B-4A62-9A0B-517A1CA12DD8

P932

Q34915928-926BB067-78E6-4C30-B842-B451FB0F7827

P356

092986711795029609

P1433

Current Medicinal Chemistry

P1476

Tumor physiology and charge dy ...... othecin-based drug development

@en

P2093

D J Adams

http://www.w3.org/2001/XMLSchema#string

L R Morgan

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting HIF-1 for cancer therapy

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro

Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient

On respiratory impairment in cancer cells

The thermodynamic dissociation constants of the anticancer drugs camptothecine, 7-ethyl-10-hydroxycamptothecine, 10-hydroxycamptothecine and 7-ethylcamptothecine by the least-squares nonlinear regression of multiwavelength spectrophotometric pH-titr

Culturing at atmospheric oxygen levels impacts lymphocyte function

Human mitochondrial topoisomerase I

BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors.

Cancer's molecular sweet tooth and the Warburg effect.

P304

1367-1372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/092986711795029609

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50265547

http://www.w3.org/2001/XMLSchema#string

P698

21366528

http://www.w3.org/2001/XMLSchema#string

P932

3086837

http://www.w3.org/2001/XMLSchema#string